English

GENZYME CORP

EDGAR

Annual report amendment (10-K/A) · filed 2011-03-24

86 filing records in this dataset, filed from 1995-05-12 to 2011-03-24. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

1.15 billion USD

2010-12-31 · USD

Exact inputs and evidence

Revenue: 4048708000 USD Source
Revenue: 2896855000 USD Source

Operating margin

9.4%

2010-12-31 · %

Exact inputs and evidence

Operating Income: 35830000 USD Source
Operating Income: -72487000 USD Source
Revenue: 4048708000 USD Source
Revenue: 2896855000 USD Source

Cash and cash equivalents: 1.33 billion USD 2010-12-31 Source
Exact value

1331112000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

4.31 billion USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Revenue: 1074473000 USD · 2010-01-01 – 2010-03-31 Source
Revenue: 1079439000 USD · 2010-04-01 – 2010-06-30 Source
Revenue: 1001800000 USD · 2010-07-01 – 2010-09-30 Source
Revenue: 4048708000 USD · 2010-01-01 – 2010-12-31 Source
Revenue: 2896855000 USD · 2010-01-01 – 2010-09-30 Source

Net income

422 million USD

2010-01-01 – 2010-12-31

Exact inputs and evidence

Net income: -114948000 USD · 2010-01-01 – 2010-03-31 Source
Net income: -3773000 USD · 2010-04-01 – 2010-06-30 Source
Net income: 68954000 USD · 2010-07-01 – 2010-09-30 Source
Net income: 422144000 USD · 2010-01-01 – 2010-12-31 Source
Net income: -49767000 USD · 2010-01-01 – 2010-09-30 Source

Operating cash flow

786 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Operating cash flow: 1179037000 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: 956581000 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: 126464000 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: 305158000 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: 126464000 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: 563946000 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: 305158000 USD · 2010-01-01 – 2010-06-30 Source

Capital expenditure

679 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Capital expenditure: 661713000 USD · 2009-01-01 – 2009-12-31 Source
Capital expenditure: 480436000 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 152220000 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 330298000 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 152220000 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 497932000 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 330298000 USD · 2010-01-01 – 2010-06-30 Source

Free cash flow

107 million USD

2009-10-01 – 2010-09-30

Exact inputs and evidence

Operating cash flow: 1179037000 USD · 2009-01-01 – 2009-12-31 Source
Operating cash flow: 956581000 USD · 2009-01-01 – 2009-09-30 Source
Operating cash flow: 126464000 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: 305158000 USD · 2010-01-01 – 2010-06-30 Source
Operating cash flow: 126464000 USD · 2010-01-01 – 2010-03-31 Source
Operating cash flow: 563946000 USD · 2010-01-01 – 2010-09-30 Source
Operating cash flow: 305158000 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 661713000 USD · 2009-01-01 – 2009-12-31 Source
Capital expenditure: 480436000 USD · 2009-01-01 – 2009-09-30 Source
Capital expenditure: 152220000 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 330298000 USD · 2010-01-01 – 2010-06-30 Source
Capital expenditure: 152220000 USD · 2010-01-01 – 2010-03-31 Source
Capital expenditure: 497932000 USD · 2010-01-01 – 2010-09-30 Source
Capital expenditure: 330298000 USD · 2010-01-01 – 2010-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2011-03-24.

Financial data available through: 2010-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2010-12-31
Operating income: 11 of 11 periods available· newest 2010-12-31
Net income: 11 of 11 periods available· newest 2010-12-31
Operating cash flow: 10 of 11 periods available· newest 2009-12-31
Capital expenditure: 10 of 11 periods available· newest 2009-12-31
Total assets: 11 of 11 periods available· newest 2010-12-31
Total liabilities: 11 of 11 periods available· newest 2010-12-31
Current assets: 11 of 11 periods available· newest 2010-12-31
Current liabilities: 11 of 11 periods available· newest 2010-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2010-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
+1.8%

Prior period

USD 3.98 billion

2009-01-01 – 2009-12-31
Current period

USD 4.05 billion

2010-01-01 – 2010-12-31

Exact inputs and evidence

4048708000 − 3977288000 = 71420000 USD

3977288000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
4048708000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GENZYME CORP · 2010-12-31 GENZYME CORP (edgar:732485) Year-over-year change in Revenue: 71420000 USD Concept: fundies:Revenue Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 4048708000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0000950123-11-020797.txt#48718 Input fundies:Revenue: 3977288000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0000950123-11-020797.txt#48718
The citation records this snapshot. The page link may show a newer release later.
Net income
0%

Prior period

USD 422.3 million

2009-01-01 – 2009-12-31
Current period

USD 422.14 million

2010-01-01 – 2010-12-31

Exact inputs and evidence

422144000 − 422300000 = -156000 USD

422300000 USD · 2009-01-01 – 2009-12-31
Inspect prior input Prior source
422144000 USD · 2010-01-01 – 2010-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GENZYME CORP · 2010-12-31 GENZYME CORP (edgar:732485) Year-over-year change in Net income: -156000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 422144000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0000950123-11-020797.txt#50924 Input fundies:NetIncome: 422300000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0000950123-11-020797.txt#50924
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Operating cash flow, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2010 2010-01-01 – 2010-12-31

Revenue USD 4.05 billion 100% of revenue
Cost of revenue USD 1.15 billion 28% of revenue
Operating expenses USD 2.4 billion 59% of revenue
Other operating costs Derived USD 457.98 million 11% of revenue
Operating income USD 35.83 million 0.9% of revenue
Tax, interest and other Derived −USD 386.31 million −9.5% of revenue
Net income USD 422.14 million 10% of revenue

Cash

Operating cash flow Unavailable An input is unavailable.
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2001 Operating loss: operating costs were 104% of revenue.
2002 Net loss: net income was −1% of revenue.
2003 Net loss: net income was −3.9% of revenue.
2004 89%
2005 16%78%
2006 Operating loss: operating costs were 106% of revenue.
2007 13%83%
2008 10%86%
2009 11%87%
2010 Net income was higher than operating income, so the split is not drawn.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2001 2001-01-01 – 2001-12-31	1223630000	1268934000 Derived	-45304000	66852000 Derived	-112156000	39875000 Derived	Source 2001-01-01 – 2001-12-31: 1223630000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -45304000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -112156000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: 224179000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 184304000 USD Inspect Capital Expenditure Open source
2002 2002-01-01 – 2002-12-31	1329472000	1217832000 Derived	111640000	124714000 Derived	-13074000	-2598000 Derived	Source 2002-01-01 – 2002-12-31: 1329472000 USD Inspect Revenue Open source 2002-01-01 – 2002-12-31: 111640000 USD Inspect Operating Income Open source 2002-01-01 – 2002-12-31: -13074000 USD Inspect Net Income Open source 2002-01-01 – 2002-12-31: 222839000 USD Inspect Operating Cash Flow Open source 2002-01-01 – 2002-12-31: 225437000 USD Inspect Capital Expenditure Open source
2003 2003-01-01 – 2003-12-31	1713871000	1682820000 Derived	31051000	98643000 Derived	-67592000	128260000 Derived	Source 2003-01-01 – 2003-12-31: 1713871000 USD Inspect Revenue Open source 2003-01-01 – 2003-12-31: 31051000 USD Inspect Operating Income Open source 2003-01-01 – 2003-12-31: -67592000 USD Inspect Net Income Open source 2003-01-01 – 2003-12-31: 387858000 USD Inspect Operating Cash Flow Open source 2003-01-01 – 2003-12-31: 259598000 USD Inspect Capital Expenditure Open source
2004 2004-01-01 – 2004-12-31	2201145000	1948232000 Derived	252913000	166386000 Derived	86527000	390112000 Derived	Source 2004-01-01 – 2004-12-31: 2201145000 USD Inspect Revenue Open source 2004-01-01 – 2004-12-31: 252913000 USD Inspect Operating Income Open source 2004-01-01 – 2004-12-31: 86527000 USD Inspect Net Income Open source 2004-01-01 – 2004-12-31: 577512000 USD Inspect Operating Cash Flow Open source 2004-01-01 – 2004-12-31: 187400000 USD Inspect Capital Expenditure Open source
2005 2005-01-01 – 2005-12-31	2734842000	2133980000 Derived	600862000	159373000 Derived	441489000	539316000 Derived	Source 2005-01-01 – 2005-12-31: 2734842000 USD Inspect Revenue Open source 2005-01-01 – 2005-12-31: 600862000 USD Inspect Operating Income Open source 2005-01-01 – 2005-12-31: 441489000 USD Inspect Net Income Open source 2005-01-01 – 2005-12-31: 731777000 USD Inspect Operating Cash Flow Open source 2005-01-01 – 2005-12-31: 192461000 USD Inspect Capital Expenditure Open source
2006 2006-01-01 – 2006-12-31	3187013000	3377522000 Derived	-190509000	-173712000 Derived	-16797000	554894000 Derived	Source 2006-01-01 – 2006-12-31: 3187013000 USD Inspect Revenue Open source 2006-01-01 – 2006-12-31: -190509000 USD Inspect Operating Income Open source 2006-01-01 – 2006-12-31: -16797000 USD Inspect Net Income Open source 2006-01-01 – 2006-12-31: 888569000 USD Inspect Operating Cash Flow Open source 2006-01-01 – 2006-12-31: 333675000 USD Inspect Capital Expenditure Open source
2007 2007-01-01 – 2007-12-31	3813519000	3159654000 Derived	653865000	173672000 Derived	480193000	505800000 Derived	Source 2007-01-01 – 2007-12-31: 3813519000 USD Inspect Revenue Open source 2007-01-01 – 2007-12-31: 653865000 USD Inspect Operating Income Open source 2007-01-01 – 2007-12-31: 480193000 USD Inspect Net Income Open source 2007-01-01 – 2007-12-31: 918672000 USD Inspect Operating Cash Flow Open source 2007-01-01 – 2007-12-31: 412872000 USD Inspect Capital Expenditure Open source
2008 2008-01-01 – 2008-12-31	4127425000	3536813000 Derived	590612000	169531000 Derived	421081000	161613000 Derived	Source 2008-01-01 – 2008-12-31: 4127425000 USD Inspect Revenue Open source 2008-01-01 – 2008-12-31: 590612000 USD Inspect Operating Income Open source 2008-01-01 – 2008-12-31: 421081000 USD Inspect Net Income Open source 2008-01-01 – 2008-12-31: 759175000 USD Inspect Operating Cash Flow Open source 2008-01-01 – 2008-12-31: 597562000 USD Inspect Capital Expenditure Open source
2009 2009-01-01 – 2009-12-31	3977288000	3467689000 Derived	509599000	87299000 Derived	422300000	517324000 Derived	Source 2009-01-01 – 2009-12-31: 3977288000 USD Inspect Revenue Open source 2009-01-01 – 2009-12-31: 509599000 USD Inspect Operating Income Open source 2009-01-01 – 2009-12-31: 422300000 USD Inspect Net Income Open source 2009-01-01 – 2009-12-31: 1179037000 USD Inspect Operating Cash Flow Open source 2009-01-01 – 2009-12-31: 661713000 USD Inspect Capital Expenditure Open source
2010 2010-01-01 – 2010-12-31	4048708000	4012878000 Derived	35830000	-386314000 Derived	422144000	Unavailable	Source 2010-01-01 – 2010-12-31: 4048708000 USD Inspect Revenue Open source 2010-01-01 – 2010-12-31: 35830000 USD Inspect Operating Income Open source 2010-01-01 – 2010-12-31: 422144000 USD Inspect Net Income Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 4B 2010

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Revenue	1223630000	Revenue: 1223630000 Open source
20022002-12-31	Revenue	1329472000	Revenue: 1329472000 Open source
20032003-12-31	Revenue	1713871000	Revenue: 1713871000 Open source
20042004-12-31	Revenue	2201145000	Revenue: 2201145000 Open source
20052005-12-31	Revenue	2734842000	Revenue: 2734842000 Open source
20062006-12-31	Revenue	3187013000	Revenue: 3187013000 Open source
20072007-12-31	Revenue	3813519000	Revenue: 3813519000 Open source
20082008-12-31	Revenue	4127425000	Revenue: 4127425000 Open source
20092009-12-31	Revenue	3977288000	Revenue: 3977288000 Open source
20102010-12-31	Revenue	4048708000	Revenue: 4048708000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

1.8% 2010

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Year over year	35.5%	Revenue: 1223630000 Open source Revenue: 903320000 Open source
20022002-12-31	Year over year	8.6%	Revenue: 1329472000 Open source Revenue: 1223630000 Open source
20032003-12-31	Year over year	28.9%	Revenue: 1713871000 Open source Revenue: 1329472000 Open source
20042004-12-31	Year over year	28.4%	Revenue: 2201145000 Open source Revenue: 1713871000 Open source
20052005-12-31	Year over year	24.2%	Revenue: 2734842000 Open source Revenue: 2201145000 Open source
20062006-12-31	Year over year	16.5%	Revenue: 3187013000 Open source Revenue: 2734842000 Open source
20072007-12-31	Year over year	19.7%	Revenue: 3813519000 Open source Revenue: 3187013000 Open source
20082008-12-31	Year over year	8.2%	Revenue: 4127425000 Open source Revenue: 3813519000 Open source
20092009-12-31	Year over year	-3.6%	Revenue: 3977288000 Open source Revenue: 4127425000 Open source
20102010-12-31	Year over year	1.8%	Revenue: 4048708000 Open source Revenue: 3977288000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin 0.9% 2010

Net margin 10.4% 2010

Free cash flow margin 13% 2009

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Operating margin	-3.7%	Operating Income: -45304000 Open source Revenue: 1223630000 Open source
20022002-12-31	Operating margin	8.4%	Operating Income: 111640000 Open source Revenue: 1329472000 Open source
20032003-12-31	Operating margin	1.8%	Operating Income: 31051000 Open source Revenue: 1713871000 Open source
20042004-12-31	Operating margin	11.5%	Operating Income: 252913000 Open source Revenue: 2201145000 Open source
20052005-12-31	Operating margin	22%	Operating Income: 600862000 Open source Revenue: 2734842000 Open source
20062006-12-31	Operating margin	-6%	Operating Income: -190509000 Open source Revenue: 3187013000 Open source
20072007-12-31	Operating margin	17.1%	Operating Income: 653865000 Open source Revenue: 3813519000 Open source
20082008-12-31	Operating margin	14.3%	Operating Income: 590612000 Open source Revenue: 4127425000 Open source
20092009-12-31	Operating margin	12.8%	Operating Income: 509599000 Open source Revenue: 3977288000 Open source
20102010-12-31	Operating margin	0.9%	Operating Income: 35830000 Open source Revenue: 4048708000 Open source
20012001-12-31	Net margin	-9.2%	Net Income: -112156000 Open source Revenue: 1223630000 Open source
20022002-12-31	Net margin	-1%	Net Income: -13074000 Open source Revenue: 1329472000 Open source
20032003-12-31	Net margin	-3.9%	Net Income: -67592000 Open source Revenue: 1713871000 Open source
20042004-12-31	Net margin	3.9%	Net Income: 86527000 Open source Revenue: 2201145000 Open source
20052005-12-31	Net margin	16.1%	Net Income: 441489000 Open source Revenue: 2734842000 Open source
20062006-12-31	Net margin	-0.5%	Net Income: -16797000 Open source Revenue: 3187013000 Open source
20072007-12-31	Net margin	12.6%	Net Income: 480193000 Open source Revenue: 3813519000 Open source
20082008-12-31	Net margin	10.2%	Net Income: 421081000 Open source Revenue: 4127425000 Open source
20092009-12-31	Net margin	10.6%	Net Income: 422300000 Open source Revenue: 3977288000 Open source
20102010-12-31	Net margin	10.4%	Net Income: 422144000 Open source Revenue: 4048708000 Open source
20012001-12-31	Free cash flow margin	3.3%	Revenue: 1223630000 Open source Operating Cash Flow: 224179000 Open source Capital Expenditure: 184304000 Open source
20022002-12-31	Free cash flow margin	-0.2%	Revenue: 1329472000 Open source Operating Cash Flow: 222839000 Open source Capital Expenditure: 225437000 Open source
20032003-12-31	Free cash flow margin	7.5%	Revenue: 1713871000 Open source Operating Cash Flow: 387858000 Open source Capital Expenditure: 259598000 Open source
20042004-12-31	Free cash flow margin	17.7%	Revenue: 2201145000 Open source Operating Cash Flow: 577512000 Open source Capital Expenditure: 187400000 Open source
20052005-12-31	Free cash flow margin	19.7%	Revenue: 2734842000 Open source Operating Cash Flow: 731777000 Open source Capital Expenditure: 192461000 Open source
20062006-12-31	Free cash flow margin	17.4%	Revenue: 3187013000 Open source Operating Cash Flow: 888569000 Open source Capital Expenditure: 333675000 Open source
20072007-12-31	Free cash flow margin	13.3%	Revenue: 3813519000 Open source Operating Cash Flow: 918672000 Open source Capital Expenditure: 412872000 Open source
20082008-12-31	Free cash flow margin	3.9%	Revenue: 4127425000 Open source Operating Cash Flow: 759175000 Open source Capital Expenditure: 597562000 Open source
20092009-12-31	Free cash flow margin	13%	Revenue: 3977288000 Open source Operating Cash Flow: 1179037000 Open source Capital Expenditure: 661713000 Open source
20102010-12-31	Free cash flow margin	Not reported	Revenue: 4048708000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD 1.2B 2009

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Operating cash flow	224179000	Operating Cash Flow: 224179000 Open source
20022002-12-31	Operating cash flow	222839000	Operating Cash Flow: 222839000 Open source
20032003-12-31	Operating cash flow	387858000	Operating Cash Flow: 387858000 Open source
20042004-12-31	Operating cash flow	577512000	Operating Cash Flow: 577512000 Open source
20052005-12-31	Operating cash flow	731777000	Operating Cash Flow: 731777000 Open source
20062006-12-31	Operating cash flow	888569000	Operating Cash Flow: 888569000 Open source
20072007-12-31	Operating cash flow	918672000	Operating Cash Flow: 918672000 Open source
20082008-12-31	Operating cash flow	759175000	Operating Cash Flow: 759175000 Open source
20092009-12-31	Operating cash flow	1179037000	Operating Cash Flow: 1179037000 Open source
20102010-12-31	Operating cash flow	Not reported	No source recorded

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD 517.3M 2009

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20012001-12-31	Free cash flow	39875000	Operating Cash Flow: 224179000 Open source Capital Expenditure: 184304000 Open source
20022002-12-31	Free cash flow	-2598000	Operating Cash Flow: 222839000 Open source Capital Expenditure: 225437000 Open source
20032003-12-31	Free cash flow	128260000	Operating Cash Flow: 387858000 Open source Capital Expenditure: 259598000 Open source
20042004-12-31	Free cash flow	390112000	Operating Cash Flow: 577512000 Open source Capital Expenditure: 187400000 Open source
20052005-12-31	Free cash flow	539316000	Operating Cash Flow: 731777000 Open source Capital Expenditure: 192461000 Open source
20062006-12-31	Free cash flow	554894000	Operating Cash Flow: 888569000 Open source Capital Expenditure: 333675000 Open source
20072007-12-31	Free cash flow	505800000	Operating Cash Flow: 918672000 Open source Capital Expenditure: 412872000 Open source
20082008-12-31	Free cash flow	161613000	Operating Cash Flow: 759175000 Open source Capital Expenditure: 597562000 Open source
20092009-12-31	Free cash flow	517324000	Operating Cash Flow: 1179037000 Open source Capital Expenditure: 661713000 Open source
20102010-12-31	Free cash flow	Unavailable	No source recorded

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

30.5% 2010

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Liabilities / assets	33.7%	Total Liabilities: 1326556000 Open source Total Assets: 3935745000 Open source
20022002-12-31	Liabilities / assets	34.1%	Total Liabilities: 1395352000 Open source Total Assets: 4093199000 Open source
20032003-12-31	Liabilities / assets	41.3%	Total Liabilities: 2068116000 Open source Total Assets: 5004528000 Open source
20042004-12-31	Liabilities / assets	27.8%	Total Liabilities: 1689265000 Open source Total Assets: 6069421000 Open source
20052005-12-31	Liabilities / assets	25.1%	Total Liabilities: 1728998000 Open source Total Assets: 6878865000 Open source
20062006-12-31	Liabilities / assets	21.3%	Total Liabilities: 1530477000 Open source Total Assets: 7191188000 Open source
20072007-12-31	Liabilities / assets	20.5%	Total Liabilities: 1701438000 Open source Total Assets: 8314375000 Open source
20082008-12-31	Liabilities / assets	15.7%	Total Liabilities: 1365283000 Open source Total Assets: 8671276000 Open source
20092009-12-31	Liabilities / assets	23.6%	Total Liabilities: 2377072000 Open source Total Assets: 10060724000 Open source
20102010-12-31	Liabilities / assets	30.5%	Total Liabilities: 3326881000 Open source Total Assets: 10913854000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.83× 2010

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20012001-12-31	Current assets / current liabilities	3×	Current Assets: 849788000 Open source Current Liabilities: 282990000 Open source
20022002-12-31	Current assets / current liabilities	2.11×	Current Assets: 1199184000 Open source Current Liabilities: 568248000 Open source
20032003-12-31	Current assets / current liabilities	3.37×	Current Assets: 1322976000 Open source Current Liabilities: 392025000 Open source
20042004-12-31	Current assets / current liabilities	2.62×	Current Assets: 1633629000 Open source Current Liabilities: 624398000 Open source
20052005-12-31	Current assets / current liabilities	3.03×	Current Assets: 1664999000 Open source Current Liabilities: 550023000 Open source
20062006-12-31	Current assets / current liabilities	3.05×	Current Assets: 1989501000 Open source Current Liabilities: 651439000 Open source
20072007-12-31	Current assets / current liabilities	1.77×	Current Assets: 2621831000 Open source Current Liabilities: 1483927000 Open source
20082008-12-31	Current assets / current liabilities	2.75×	Current Assets: 2516135000 Open source Current Liabilities: 914283000 Open source
20092009-12-31	Current assets / current liabilities	2.59×	Current Assets: 2802803000 Open source Current Liabilities: 1080130000 Open source
20102010-12-31	Current assets / current liabilities	2.83×	Current Assets: 3700958000 Open source Current Liabilities: 1305965000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2001 2001-01-01 – 2001-12-31	−USD 112.16 million Exact value Exact value: -112156000 USD 2001-01-01 – 2001-12-31: -112156000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENZYME CORP · 2001-12-31 GENZYME CORP (edgar:732485) Net Income: -112156000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -112156000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-04-007949.txt#24126 The citation records this snapshot. The page link may show a newer release later.	USD 224.18 million Exact value Exact value: 224179000 USD 2001-01-01 – 2001-12-31: 224179000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENZYME CORP · 2001-12-31 GENZYME CORP (edgar:732485) Operating Cash Flow: 224179000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 224179000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-04-007949.txt#24483 The citation records this snapshot. The page link may show a newer release later.	USD 184.3 million Exact value Exact value: 184304000 USD 2001-01-01 – 2001-12-31: 184304000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENZYME CORP · 2001-12-31 GENZYME CORP (edgar:732485) Capital Expenditure: 184304000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 184304000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-04-007949.txt#24579 The citation records this snapshot. The page link may show a newer release later.	USD 39.88 million Calculation and evidence 224179000 − 184304000 USD Exact free cash flow: 39875000 USD 2001-01-01 – 2001-12-31: 224179000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 184304000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENZYME CORP · 2001-12-31 GENZYME CORP (edgar:732485) Free cash flow: 39875000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 224179000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-04-007949.txt#24483 Input fundies:CapitalExpenditure: 184304000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-04-007949.txt#24579 The citation records this snapshot. The page link may show a newer release later.
2002 2002-01-01 – 2002-12-31	−USD 13.07 million Exact value Exact value: -13074000 USD 2002-01-01 – 2002-12-31: -13074000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENZYME CORP · 2002-12-31 GENZYME CORP (edgar:732485) Net Income: -13074000 USD Concept: fundies:NetIncome Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ANetIncome&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13074000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-05-006417.txt#24251 The citation records this snapshot. The page link may show a newer release later.	USD 222.84 million Exact value Exact value: 222839000 USD 2002-01-01 – 2002-12-31: 222839000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENZYME CORP · 2002-12-31 GENZYME CORP (edgar:732485) Operating Cash Flow: 222839000 USD Concept: fundies:OperatingCashFlow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3AOperatingCashFlow&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 222839000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-05-006417.txt#24593 The citation records this snapshot. The page link may show a newer release later.	USD 225.44 million Exact value Exact value: 225437000 USD 2002-01-01 – 2002-12-31: 225437000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENZYME CORP · 2002-12-31 GENZYME CORP (edgar:732485) Capital Expenditure: 225437000 USD Concept: fundies:CapitalExpenditure Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ACapitalExpenditure&period=2002-12-31&surface=latest&period_type=duration&start=2002-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 225437000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-05-006417.txt#24689 The citation records this snapshot. The page link may show a newer release later.	−USD 2.6 million Calculation and evidence 222839000 − 225437000 USD Exact free cash flow: -2598000 USD 2002-01-01 – 2002-12-31: 222839000 USD · Inspect Operating Cash Flow · Source 2002-01-01 – 2002-12-31: 225437000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENZYME CORP · 2002-12-31 GENZYME CORP (edgar:732485) Free cash flow: -2598000 USD Concept: free-cash-flow Period: 2002-01-01 to 2002-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 222839000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-05-006417.txt#24593 Input fundies:CapitalExpenditure: 225437000 USD (2002-01-01 to 2002-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-05-006417.txt#24689 The citation records this snapshot. The page link may show a newer release later.
2003 2003-01-01 – 2003-12-31	−USD 67.59 million Exact value Exact value: -67592000 USD 2003-01-01 – 2003-12-31: -67592000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENZYME CORP · 2003-12-31 GENZYME CORP (edgar:732485) Net Income: -67592000 USD Concept: fundies:NetIncome Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ANetIncome&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:NetIncome: -67592000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-06-003142.txt#20218 The citation records this snapshot. The page link may show a newer release later.	USD 387.86 million Exact value Exact value: 387858000 USD 2003-01-01 – 2003-12-31: 387858000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENZYME CORP · 2003-12-31 GENZYME CORP (edgar:732485) Operating Cash Flow: 387858000 USD Concept: fundies:OperatingCashFlow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3AOperatingCashFlow&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 387858000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-06-003142.txt#20561 The citation records this snapshot. The page link may show a newer release later.	USD 259.6 million Exact value Exact value: 259598000 USD 2003-01-01 – 2003-12-31: 259598000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENZYME CORP · 2003-12-31 GENZYME CORP (edgar:732485) Capital Expenditure: 259598000 USD Concept: fundies:CapitalExpenditure Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ACapitalExpenditure&period=2003-12-31&surface=latest&period_type=duration&start=2003-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 259598000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-06-003142.txt#20657 The citation records this snapshot. The page link may show a newer release later.	USD 128.26 million Calculation and evidence 387858000 − 259598000 USD Exact free cash flow: 128260000 USD 2003-01-01 – 2003-12-31: 387858000 USD · Inspect Operating Cash Flow · Source 2003-01-01 – 2003-12-31: 259598000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENZYME CORP · 2003-12-31 GENZYME CORP (edgar:732485) Free cash flow: 128260000 USD Concept: free-cash-flow Period: 2003-01-01 to 2003-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 387858000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-06-003142.txt#20561 Input fundies:CapitalExpenditure: 259598000 USD (2003-01-01 to 2003-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-06-003142.txt#20657 The citation records this snapshot. The page link may show a newer release later.
2004 2004-01-01 – 2004-12-31	USD 86.53 million Exact value Exact value: 86527000 USD 2004-01-01 – 2004-12-31: 86527000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENZYME CORP · 2004-12-31 GENZYME CORP (edgar:732485) Net Income: 86527000 USD Concept: fundies:NetIncome Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ANetIncome&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:NetIncome: 86527000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001104659-07-015489.txt#36968 The citation records this snapshot. The page link may show a newer release later.	USD 577.51 million Exact value Exact value: 577512000 USD 2004-01-01 – 2004-12-31: 577512000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENZYME CORP · 2004-12-31 GENZYME CORP (edgar:732485) Operating Cash Flow: 577512000 USD Concept: fundies:OperatingCashFlow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3AOperatingCashFlow&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 577512000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001104659-07-015489.txt#37555 The citation records this snapshot. The page link may show a newer release later.	USD 187.4 million Exact value Exact value: 187400000 USD 2004-01-01 – 2004-12-31: 187400000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENZYME CORP · 2004-12-31 GENZYME CORP (edgar:732485) Capital Expenditure: 187400000 USD Concept: fundies:CapitalExpenditure Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ACapitalExpenditure&period=2004-12-31&surface=latest&period_type=duration&start=2004-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 187400000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001104659-07-015489.txt#37712 The citation records this snapshot. The page link may show a newer release later.	USD 390.11 million Calculation and evidence 577512000 − 187400000 USD Exact free cash flow: 390112000 USD 2004-01-01 – 2004-12-31: 577512000 USD · Inspect Operating Cash Flow · Source 2004-01-01 – 2004-12-31: 187400000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENZYME CORP · 2004-12-31 GENZYME CORP (edgar:732485) Free cash flow: 390112000 USD Concept: free-cash-flow Period: 2004-01-01 to 2004-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 577512000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001104659-07-015489.txt#37555 Input fundies:CapitalExpenditure: 187400000 USD (2004-01-01 to 2004-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001104659-07-015489.txt#37712 The citation records this snapshot. The page link may show a newer release later.
2005 2005-01-01 – 2005-12-31	USD 441.49 million Exact value Exact value: 441489000 USD 2005-01-01 – 2005-12-31: 441489000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENZYME CORP · 2005-12-31 GENZYME CORP (edgar:732485) Net Income: 441489000 USD Concept: fundies:NetIncome Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ANetIncome&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:NetIncome: 441489000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-08-002100.txt#13710 The citation records this snapshot. The page link may show a newer release later.	USD 731.78 million Exact value Exact value: 731777000 USD 2005-01-01 – 2005-12-31: 731777000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENZYME CORP · 2005-12-31 GENZYME CORP (edgar:732485) Operating Cash Flow: 731777000 USD Concept: fundies:OperatingCashFlow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3AOperatingCashFlow&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 731777000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-08-002100.txt#14023 The citation records this snapshot. The page link may show a newer release later.	USD 192.46 million Exact value Exact value: 192461000 USD 2005-01-01 – 2005-12-31: 192461000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENZYME CORP · 2005-12-31 GENZYME CORP (edgar:732485) Capital Expenditure: 192461000 USD Concept: fundies:CapitalExpenditure Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ACapitalExpenditure&period=2005-12-31&surface=latest&period_type=duration&start=2005-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 192461000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-08-002100.txt#14123 The citation records this snapshot. The page link may show a newer release later.	USD 539.32 million Calculation and evidence 731777000 − 192461000 USD Exact free cash flow: 539316000 USD 2005-01-01 – 2005-12-31: 731777000 USD · Inspect Operating Cash Flow · Source 2005-01-01 – 2005-12-31: 192461000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENZYME CORP · 2005-12-31 GENZYME CORP (edgar:732485) Free cash flow: 539316000 USD Concept: free-cash-flow Period: 2005-01-01 to 2005-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 731777000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-08-002100.txt#14023 Input fundies:CapitalExpenditure: 192461000 USD (2005-01-01 to 2005-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-08-002100.txt#14123 The citation records this snapshot. The page link may show a newer release later.
2006 2006-01-01 – 2006-12-31	−USD 16.8 million Exact value Exact value: -16797000 USD 2006-01-01 – 2006-12-31: -16797000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENZYME CORP · 2006-12-31 GENZYME CORP (edgar:732485) Net Income: -16797000 USD Concept: fundies:NetIncome Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ANetIncome&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:NetIncome: -16797000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-09-002134.txt#15967 The citation records this snapshot. The page link may show a newer release later.	USD 888.57 million Exact value Exact value: 888569000 USD 2006-01-01 – 2006-12-31: 888569000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENZYME CORP · 2006-12-31 GENZYME CORP (edgar:732485) Operating Cash Flow: 888569000 USD Concept: fundies:OperatingCashFlow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3AOperatingCashFlow&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 888569000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-09-002134.txt#16280 The citation records this snapshot. The page link may show a newer release later.	USD 333.68 million Exact value Exact value: 333675000 USD 2006-01-01 – 2006-12-31: 333675000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENZYME CORP · 2006-12-31 GENZYME CORP (edgar:732485) Capital Expenditure: 333675000 USD Concept: fundies:CapitalExpenditure Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ACapitalExpenditure&period=2006-12-31&surface=latest&period_type=duration&start=2006-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 333675000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-09-002134.txt#16380 The citation records this snapshot. The page link may show a newer release later.	USD 554.89 million Calculation and evidence 888569000 − 333675000 USD Exact free cash flow: 554894000 USD 2006-01-01 – 2006-12-31: 888569000 USD · Inspect Operating Cash Flow · Source 2006-01-01 – 2006-12-31: 333675000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENZYME CORP · 2006-12-31 GENZYME CORP (edgar:732485) Free cash flow: 554894000 USD Concept: free-cash-flow Period: 2006-01-01 to 2006-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 888569000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-09-002134.txt#16280 Input fundies:CapitalExpenditure: 333675000 USD (2006-01-01 to 2006-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-09-002134.txt#16380 The citation records this snapshot. The page link may show a newer release later.
2007 2007-01-01 – 2007-12-31	USD 480.19 million Exact value Exact value: 480193000 USD 2007-01-01 – 2007-12-31: 480193000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENZYME CORP · 2007-12-31 GENZYME CORP (edgar:732485) Net Income: 480193000 USD Concept: fundies:NetIncome Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ANetIncome&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:NetIncome: 480193000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#16652 The citation records this snapshot. The page link may show a newer release later.	USD 918.67 million Exact value Exact value: 918672000 USD 2007-01-01 – 2007-12-31: 918672000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENZYME CORP · 2007-12-31 GENZYME CORP (edgar:732485) Operating Cash Flow: 918672000 USD Concept: fundies:OperatingCashFlow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3AOperatingCashFlow&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 918672000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#16934 The citation records this snapshot. The page link may show a newer release later.	USD 412.87 million Exact value Exact value: 412872000 USD 2007-01-01 – 2007-12-31: 412872000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENZYME CORP · 2007-12-31 GENZYME CORP (edgar:732485) Capital Expenditure: 412872000 USD Concept: fundies:CapitalExpenditure Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ACapitalExpenditure&period=2007-12-31&surface=latest&period_type=duration&start=2007-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 412872000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#17034 The citation records this snapshot. The page link may show a newer release later.	USD 505.8 million Calculation and evidence 918672000 − 412872000 USD Exact free cash flow: 505800000 USD 2007-01-01 – 2007-12-31: 918672000 USD · Inspect Operating Cash Flow · Source 2007-01-01 – 2007-12-31: 412872000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENZYME CORP · 2007-12-31 GENZYME CORP (edgar:732485) Free cash flow: 505800000 USD Concept: free-cash-flow Period: 2007-01-01 to 2007-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 918672000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#16934 Input fundies:CapitalExpenditure: 412872000 USD (2007-01-01 to 2007-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#17034 The citation records this snapshot. The page link may show a newer release later.
2008 2008-01-01 – 2008-12-31	USD 421.08 million Exact value Exact value: 421081000 USD 2008-01-01 – 2008-12-31: 421081000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENZYME CORP · 2008-12-31 GENZYME CORP (edgar:732485) Net Income: 421081000 USD Concept: fundies:NetIncome Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ANetIncome&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:NetIncome: 421081000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0000950123-11-020797.txt#50924 The citation records this snapshot. The page link may show a newer release later.	USD 759.18 million Exact value Exact value: 759175000 USD 2008-01-01 – 2008-12-31: 759175000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENZYME CORP · 2008-12-31 GENZYME CORP (edgar:732485) Operating Cash Flow: 759175000 USD Concept: fundies:OperatingCashFlow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3AOperatingCashFlow&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 759175000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#16934 The citation records this snapshot. The page link may show a newer release later.	USD 597.56 million Exact value Exact value: 597562000 USD 2008-01-01 – 2008-12-31: 597562000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENZYME CORP · 2008-12-31 GENZYME CORP (edgar:732485) Capital Expenditure: 597562000 USD Concept: fundies:CapitalExpenditure Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ACapitalExpenditure&period=2008-12-31&surface=latest&period_type=duration&start=2008-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 597562000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#17034 The citation records this snapshot. The page link may show a newer release later.	USD 161.61 million Calculation and evidence 759175000 − 597562000 USD Exact free cash flow: 161613000 USD 2008-01-01 – 2008-12-31: 759175000 USD · Inspect Operating Cash Flow · Source 2008-01-01 – 2008-12-31: 597562000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENZYME CORP · 2008-12-31 GENZYME CORP (edgar:732485) Free cash flow: 161613000 USD Concept: free-cash-flow Period: 2008-01-01 to 2008-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 759175000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#16934 Input fundies:CapitalExpenditure: 597562000 USD (2008-01-01 to 2008-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#17034 The citation records this snapshot. The page link may show a newer release later.
2009 2009-01-01 – 2009-12-31	USD 422.3 million Exact value Exact value: 422300000 USD 2009-01-01 – 2009-12-31: 422300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENZYME CORP · 2009-12-31 GENZYME CORP (edgar:732485) Net Income: 422300000 USD Concept: fundies:NetIncome Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ANetIncome&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:NetIncome: 422300000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0000950123-11-020797.txt#50924 The citation records this snapshot. The page link may show a newer release later.	USD 1.18 billion Exact value Exact value: 1179037000 USD 2009-01-01 – 2009-12-31: 1179037000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENZYME CORP · 2009-12-31 GENZYME CORP (edgar:732485) Operating Cash Flow: 1179037000 USD Concept: fundies:OperatingCashFlow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3AOperatingCashFlow&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: 1179037000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#16934 The citation records this snapshot. The page link may show a newer release later.	USD 661.71 million Exact value Exact value: 661713000 USD 2009-01-01 – 2009-12-31: 661713000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENZYME CORP · 2009-12-31 GENZYME CORP (edgar:732485) Capital Expenditure: 661713000 USD Concept: fundies:CapitalExpenditure Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ACapitalExpenditure&period=2009-12-31&surface=latest&period_type=duration&start=2009-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 661713000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#17034 The citation records this snapshot. The page link may show a newer release later.	USD 517.32 million Calculation and evidence 1179037000 − 661713000 USD Exact free cash flow: 517324000 USD 2009-01-01 – 2009-12-31: 1179037000 USD · Inspect Operating Cash Flow · Source 2009-01-01 – 2009-12-31: 661713000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENZYME CORP · 2009-12-31 GENZYME CORP (edgar:732485) Free cash flow: 517324000 USD Concept: free-cash-flow Period: 2009-01-01 to 2009-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: 1179037000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#16934 Input fundies:CapitalExpenditure: 661713000 USD (2009-01-01 to 2009-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0001047469-10-001574.txt#17034 The citation records this snapshot. The page link may show a newer release later.
2010 2010-01-01 – 2010-12-31	USD 422.14 million Exact value Exact value: 422144000 USD 2010-01-01 – 2010-12-31: 422144000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENZYME CORP · 2010-12-31 GENZYME CORP (edgar:732485) Net Income: 422144000 USD Concept: fundies:NetIncome Period: 2010-01-01 to 2010-12-31 Values: Latest reported Published: 2026-11-02T12:31:48Z Snapshot: 81ee0eafc8149fdacd62b43bf0e84a7b23a7d8829a305759c7d1c215b9d42860 Dimensions: Consolidated View: https://fundies.io/companies/edgar/732485/explain?concept=fundies%3ANetIncome&period=2010-12-31&surface=latest&period_type=duration&start=2010-01-01&unit=USD&dimensions= Input fundies:NetIncome: 422144000 USD (2010-01-01 to 2010-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/732485/0000950123-11-020797.txt#50924 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Operating cash flow + Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

86 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000732485, 732485, edgar:732485

GENZYME CORP

Latest quarter

Revenue

Operating margin

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Where revenue goes

2010 2010-01-01 – 2010-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation